Anzeige
+++Hot Stock!: China kontrolliert Antimon, eines der hochgradigsten Projekte der Welt?! China kontrolliert Antimon, eines der hochgradigsten Projekte der Welt?!+++
AUXLY CANNABIS WKN: A2JNSX ISIN: CA05335P1099 Kürzel: XLY Forum: Aktien Thema: Hauptdiskussion
0,0884
EUR
±0,00 % ±0,0000
17:21:46 Uhr,
Lang & Schwarz
Kommentare 15.239
Bowmore25,
12.04.2019 13:23 Uhr
0
Naja seitwärts...
four_twenty,
11.04.2019 20:42 Uhr
0
Wo läuft hier was
R
Retter2,
09.04.2019 12:15 Uhr
0
Es läuft :)
b
btza,
08.04.2019 23:37 Uhr
0
guad
M
Mr.MS,
08.04.2019 19:24 Uhr
0
Nicht schkecht
Alf1,
08.04.2019 19:01 Uhr
0
VANCOUVER, BC, 08.04.2019. (GLOBE NEWSWIRE)
Die Auxly Cannabis Group Inc. gab heute bekannt, dass ihre hundertprozentige Tochtergesellschaft Robinsons Cannabis Inc. („Robinsons“) wurden von Health Canada gemäß dem Cannabis Act und der Cannabis-Verordnung standardisierte Anbau- und Verarbeitungslizenzen erteilt. Die Lizenzen geben Robinsons die Möglichkeit, die Kultivierung in seiner vollständig erbauten, rund 700 Quadratmeter großen Anlage in Kentville, Nova Scotia, zu beginnen, die speziell für die Herstellung von hochwertigem Cannabis gebaut wurde.
„Wir freuen uns, diesen wichtigen Meilenstein erreicht zu haben“, sagt Andrew Robinson. „Unser Ziel ist es, den bestmöglichen Cannabis für Cannabiskenner wie uns selbst herzustellen. Mit den Lizenzen können wir mit der Produktion beginnen und Schritte unternehmen, um ein konsistentes Endprodukt zu liefern, das auf Geschmack, Geruch und Wirksamkeit ausgerichtet ist. “
XLY erwartet, dass die erstklassigen Produkte von Robinsons im vierten Quartal dieses Jahres zum Verkauf angeboten werden, vorbehaltlich der Genehmigung des Vertriebs von Health Canada. Mit dem Fokus auf Qualität plant Robinsons, eine begrenzte Produktmenge von etwa 1.100 kg pro Jahr auf den Markt zu bringen.
Im Namen des Vorstandes Chuck Rifici Vorsitzender & CEO
✅✅✅✅✅✅✅✅✅✅
F
FabS,
08.04.2019 13:46 Uhr
0
Technical420
Toggle navigation
MENU
Previous Page Back
Auxly Announces Receipt of Cultivation and Processing Licences for Robinsons Cannabis Facility
INDUSTRY Apr 8, 2019 • 11:02 AM GMT+0000
5 MIN READ • BY ANTHONY VARRELL
Auxly Cannabis Group Inc. (TSX.V – XLY) (“Auxly” or the “Company“) today announced that its wholly-owned subsidiary, Robinsons Cannabis Inc. (“Robinsons”), has been granted standard cultivation and processing licences by Health Canada pursuant to the Cannabis Act and Cannabis Regulations. The licences give Robinsons the ability to begin cultivation at its fully constructed 27,700 square-foot facility in Kentville, Nova Scotia, which was purpose-built to produce high-quality cannabis.
Led by experienced head grower Andrew Robinson, Robinsons is uniquely positioned to capture the attention of luxury cannabis consumers, with operations built on a devotion to uncompromising quality and a premium cannabis experience. Robinsons products have consistently ranked the highest in terms of cannabinoid content, terpene content and overall quality when independently tested against 5,000 products supplied by various growers licenced in accordance with Canadian cannabis regulations.
“We are thrilled to have achieved this major milestone,” says Andrew Robinson. “Our goal is to produce the best cannabis we can, for cannabis connoisseurs like ourselves. The licences will allow us to start production and take steps toward delivering a consistent final product focused on taste, smell, and potency.”
Hugo Alves, President of Auxly said: “This is a big milestone for one of our key subsidiaries and member of the Auxly family. We know that Andrew and his team are going to produce some of the best cannabis flower available in Canada and we can’t wait to share it with Canadian consumers. Robinsons is all about an unwavering commitment to quality. We hope to show cannabis connoisseurs, who to date have been generally disappointed with the flower offerings in the market, that passionate artisans operating in the regulated industry can produce an incredible product that reflects their pride and craftsmanship.”
Auxly expects that Robinsons’ premier products will be available for sale in the fourth quarter of this year, subject to receipt of sales authorization from Health Canada. With a focus on quality, Robinsons plans to release a limited amount of product to the market of approximately 1,100kg per year.
ON BEHALF OF THE BOARD
“Chuck Rifici” Chairman & CEO
About Auxly Cannabis Group Inc. (TSX.V: XLY)
Auxly is a vertically integrated cannabis company with diverse operations across Canada and Uruguay and a platform spanning the entire cannabis value chain. The Company relies upon its diversified cannabis cultivation platform, its leading research and development infrastructure, its domestic and international distribution platform and its experienced team of industry leaders and strategic partners in order to serve an evolving global cannabis market.
Investor Relations:
For more information about investing in Auxly Cannabis Group, please visit: http://www.auxly.com or contact our Investor Relations Team:
Email: IR@auxly.com
Phone: 1.833.695.2414
Stay Connected:
Follow up on *** @Auxlygroup
Media Enquiries (only):
For media enquiries or to set up an interview please contact:
Sarah Bain, VP External Affairs
Email: sarah@auxly.com
Phone: 613.230.5869
Notice Regarding Forward Looking Information:
This news release contains certain “forward-looking information” within the meaning of applicable Canadian securities law. Forward-looking information is frequently characterized by words such as “plan”, “continue”, “expect”, “project”, “intend”, “believe”, “anticipate”, “estimate”, “may”, “will”, “potential”, “proposed” and other similar words, or information that certain events or conditions “may” or “will” occur. This information is only a prediction. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking information throughout this news release. Forward-looking information includes, but is not limited to: expectations of future growing capacity at the Robinsons facility; political change, future legislative and regulatory developments involving cannabis; and competition and other risks affecting the Company in particular and the cannabis industry generally.
A number of factors could cause actual results to differ materially from a conclusion, forecast or projection contained in the forward-looking information in this release including, but not limited to, whether: Robinsons is able to maintain the Cultivation License and obtain a sales licence; Robinsons can obtain all necessary governmental and regulatory permits and approvals for the facility, and whether such permits and approvals can be obtained in a timely manner; and general economic, financial market, regulatory and political conditions in which the Company operates will remain the same. Additional risk factors are disclosed in the revised annual information form of the Company for the financial year ended December 31, 2017 dated May 24, 2018.
New factors emerge from time to time, and it is not possible for management to predict all of those factors or to assess in advance the impact of each such factor on the Company’s business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking information. The forward-looking information in this release is based on information currently available and what management believes are reasonable assumptions. Forward-looking information speaks only to such assumptions as of the date of this release. In addition, this release may contain forward-looking information attributed to third party industry sources, the accuracy of which has not been verified by the Company. The purpose of forward-looking information is to provide the reader with a description of management’s expectations, and such forward-looking information may not be appropriate for any other purpose. Readers should not place undue reliance on forward-looking information contained in this release.
The forward-looking information contained in this release is expressly qualified by the foregoing cautionary statements and is *** as of the date of this release. Except as may be required by applicable securities laws, the Company does not undertake any obligation to publicly update or revise any forward-looking information to reflect events or circumstances after the date of this release or to reflect the occurrence of unanticipated events, whether as a result of new information, future events or results, or otherwise.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Primary Logo
Source: GlobeNewswire (April 8, 2019 – 7:00 AM EDT)
News by QuoteMedia
www.quotemedia.com
Share Share - *** Share - ***
Tags
AUXLYCANNABIS STREAMINGCBWTFCULTIVATIONCULTIVATION LICENSEXLY
AUTHORED BY
Anthony Varrell
Anthony Varrell is Managing Director of StoneBridge Partners LLC. SBP continues to drive market awareness for leading firms in the cannabis industry throughout the U.S. and abroad.
Related Articles
Cannabis earnings.png Auxly Bolsters Management Team
Cannabis (59).png Auxly Signs Definitive Agreement With Curative Cannabis
Cannabis (29).png Auxly Announces Completion of Inverell S.A. Acquisition
Cannabis (50).png Dixie Brands confirms plan to introduce full *** of cannabis-infused products in Canada
Comments
ADVERTISEMENT
t420-ad-300x250.png
Top Stories
GLOBAL
Aurora Cannabis Inc. Files Preliminary Base Shelf Prospectus
EDITORIAL
4 Cannabis Stocks To Watch After Reporting Promising Earnings
GLOBAL
Aurora Cannabis Awarded Maximum Number of Lots in German Cannabis Production Tender
Get the Latest Cannabis News & Stock Picks.
Enter your email below to join the official Technical420 newsletter.
Enter your email
All good -- no spamming here.
QUICK LINKS
Home
Market
Reports
Membership
About Us
Login
Signup
Contact Us
Disclosures
ABOUT
Technical420 is dedicated to educating investors about the risk and rewards of investing in the cannabis industry. We highlight companies that have the most growth potential by utilizing our proprietary analytics platform.
LEGAL
Technical420, LLC. is not a licensed broker-dealer, market maker, investment advisor, or underwriter. All information that we provide is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Furthermore, investing in such securities involves substantial risk of loss and investors should seek advice from financial professionals before investing.
JOIN THE NEWSLETTER
Subscribe now and learn how you can capitalize on the Green Age!
Enter your email
FOLLOW
Technical420
©2019 Technical420 LLC – All Rights Reserved.
Alf1,
05.04.2019 22:21 Uhr
0
bis 2021 müssen wir noch warten ; lol ✌️
b
btza,
05.04.2019 7:50 Uhr
0
Gut so
K
Krisu,
04.04.2019 19:30 Uhr
0
Ja, wundert mich auch. Bin aber auch froh darüber !!!
Z
Zenker,
04.04.2019 19:19 Uhr
0
Also dafür das die Zahlen so miserabel waren und abgestürzt ist, erholt die sich sehr gut
Alf1,
04.04.2019 15:43 Uhr
0
https://midasletter.com/2019/04/delta-9-cannabis-cvenine-ceo-saskatchewan-private-retail-supply-agreement/
F
FC_Hollywood,
03.04.2019 13:57 Uhr
0
Bayer... Da habe ich bei 56€ überlegt aber weiter gewartet. Hinterher ist man schlauer ;) Kenne deinen EK nicht aber auf die 65€ würde ich schon noch warten.
Steinhoff wird spannend ja, denke auch eher upside statt Verlust.
So nun wieder Auxly ;)
F
Fischbrötchen,
03.04.2019 13:47 Uhr
0
ich-bin-noch-immer-mit-ueber-60-cash-unterwegs-pfandbriefbank-hab-ich-im-januar-zu-9-05-zugekauft-und-bei-bayer-hab-ich-nach-dem-urteil-letzte-woche-zugeschlagen-pbb-bleibt-bis-zur-dividende-im-mai-im-depot--bei-bayer-bin-ich-unentschlossen-und-neige-eigentlich-zur-gewinnmitnahme-andererseits-ist-bayer-gerade-an-der-boerse-nur-noch-aehnlich-viel-wert-wie-der-kaufpreis-fuer-monsanto-passt-auch-irgendwie-nicht-recht-zusammennaja-und-gezockt-wird-derweil-mit-snh-da-kommen-ende-des-monats-ja-die-korrigierten-bilanzen-hopp-oder-top-da-bin-ich-auf-nen-totalverlust-eingestellt--sehe-aber-echte-chancen-auf-einen-vervielfacher
F
FC_Hollywood,
03.04.2019 12:54 Uhr
0
Gier gibt es eben auch auf der Einkaufsseite ;-)
F
FC_Hollywood,
03.04.2019 12:53 Uhr
0
Sorry für OT aber @wichel: ist deine Cash-Quote nach wie vor hoch oder bist du aktuell stärker investiert?
Ich ärgere mich schwarz weil ich zu lang nur Zuschauer war. Sixt, Daimler, Tesla, Nvidia,... Da hätte man in den letzten Wochen und Monaten schönes Geld machen können.
Das meine ich mit meiner Aussage von gestern, dass mich entgangene Gewinne weitaus mehr stören als rote Prozente.
Mehr zu diesem Wert
|
|
Thema | ||
|---|---|---|---|
| 1 | AUXLY CANNABIS Hauptdiskussion | ||
| 2 | Auxly Investoren Gruppe (18+) |
Meistdiskutiert
|
|
Thema | ||
|---|---|---|---|
| 1 | DAX Hauptdiskussion | -1,76 % | |
| 2 | RENK (für normale, sachliche Kommunikation!) | -0,39 % | |
| 3 | Aktuelles zu Almonty Industries | +0,07 % | |
| 4 | RHEINMETALL Hauptdiskussion | +2,20 % | |
| 5 | BTC/USD Hauptdiskussion | -0,01 % | |
| 6 | NVIDIA Hauptdiskussion | ±0,00 % | |
| 7 | APOLLO MINERALS Hauptdiskussion | ±0,00 % | |
| 8 | ATOS Hauptdiskussion | ±0,00 % | |
| 9 | EVOTEC Hauptdiskussion | -0,06 % | |
| 10 | Diginex | -2,31 % | Alle Diskussionen |
Aktien
|
|
Thema | ||
|---|---|---|---|
| 1 | Aktuelles zu Almonty Industries | +0,07 % | |
| 2 | RENK (für normale, sachliche Kommunikation!) | -0,39 % | |
| 3 | RHEINMETALL Hauptdiskussion | +2,20 % | |
| 4 | EVOTEC Hauptdiskussion | -0,06 % | |
| 5 | ATOS Hauptdiskussion | ±0,00 % | |
| 6 | APOLLO MINERALS Hauptdiskussion | ±0,00 % | |
| 7 | NVIDIA Hauptdiskussion | ±0,00 % | |
| 8 | BYD Hauptdiskussion | ±0,00 % | |
| 9 | Diginex | -2,31 % | |
| 10 | EOS - Verteidigungs- und Raumfahrttechnik | +1,94 % | Alle Diskussionen |